Eurazeo stock slips after H1 2026 results as investors eye private equity exits

Eurazeo stock trades below 50 euros on Euronext Paris after the H1 2026 earnings update, with investors weighing slower share performance against growing proceeds from private equity portfolio disposals.

Eurazeo stock (ISIN FR0000121121) closed at 48.90 EUR on Euronext Paris on September 2, 2026, down 1.25% for the day according to data from Zonebourse.

H1 2026 earnings frame the valuation

In its H1 2026 earnings communication, Eurazeo highlighted the performance of its private equity and investment activities, with the half-year results presentation and call held on July 23, 2026, as referenced by financial portal Zonebourse. While detailed line items are not broken out in the latest snippets, the period confirms that investors are now trading the stock on the basis of 2026 mid-year figures rather than historical 2023 numbers.

The H1 2026 report follows a multi-year strategy in which Eurazeo has recycled capital through asset disposals and reinvestment. An external analysis of Eurazeo’s deal activity notes that a planned majority sale of the Aroma-Zone natural and DIY beauty business to Partners Group would generate about 576 million EUR of gross proceeds for Eurazeo, compared with roughly 410 million EUR invested five years earlier, implying an indicated uplift of around 166 million EUR on this single asset before fees and reinvestment, according to a transaction overview compiled by Taylor Sicard on September 2, 2026.

Stock performance and valuation signals

Price data from Zonebourse show that Eurazeo closed at 48.90 EUR on September 2, 2026, after a 1.25% daily decline, with a trading volume of 68,739 shares on Euronext Paris. Over the past week, the stock is down 4.02%, while the year-to-date performance stands at minus 8.26%, underperforming the broader SBF 120 index, which closed at 6,291.68 points on September 1, 2026, based on Euronext index data.

Valuation data from Morningstar indicate that Eurazeo traded at 53.25 EUR as of September 1, 2026, and that analysts on that platform assign a fair value estimate of 33.60 EUR per share, implying that at that snapshot the stock was trading at a premium of several tens of percent to that fair value marker. Morningstar also shows a 52-week range from 50.65 EUR to 80.90 EUR, meaning that at a recent price level near 49.52 EUR cited for September 1, 2026, the stock is now trading close to its 52-week low and significantly below its 52-week high of 80.90 EUR, a gap of more than 30 EUR per share.

Private equity portfolio and Aroma-Zone deal

Eurazeo’s strategy is heavily driven by its private equity portfolio, where disposals can release capital and crystallize value. A recent sector overview of consumer brand acquisitions in 2026 notes that Partners Group is in exclusive discussions to acquire a majority stake in Aroma-Zone from Eurazeo, with the transaction expected to deliver about 576 million EUR of gross proceeds to Eurazeo and to leave the group reinvesting as a minority shareholder after initially committing about 410 million EUR roughly five years earlier. This indicates a substantial value creation on this asset and underscores the potential for further gains from portfolio exits if market conditions permit.

For investors in Eurazeo stock, such transactions are important because realized proceeds can support new investments, shareholder distributions or balance sheet strength. At the same time, the pipeline of exits and the valuations achieved influence how the market discounts the net asset value of Eurazeo’s funds and balance sheet. The recent share price trading near the lower end of the 52-week range suggests that investors remain cautious despite evidence of value creation in single deals like Aroma-Zone.

Eurazeo’s consumer investments as an example

One representative segment for Eurazeo is consumer brands, where the group has backed companies like Aroma-Zone in beauty and wellness. The planned Aroma-Zone transaction shows how Eurazeo’s consumer portfolio can progress from initial investment to partial or full exit, with the cited 576 million EUR of expected gross proceeds versus about 410 million EUR invested highlighting the scale of potential capital recycling when deals complete successfully.

Current stock level for investors

As of the Euronext Paris close on September 2, 2026, Eurazeo stock changed hands at 48.90 EUR, with the stock recently trading in a 52-week corridor between 50.65 EUR and 80.90 EUR and showing a year-to-date performance of minus 8.26% on figures compiled by Zonebourse and Morningstar. For investors, the key question now is how quickly Eurazeo can translate its H1 2026 portfolio progress and pending transactions like the Aroma-Zone deal into sustained earnings growth and a re-rating of the share price.

Eurazeo stock at a glance

• Company: Eurazeo SE
• ISIN: FR0000121121
• Ticker: RF
• Trading venue: Euronext Paris
• Price (as of September 2, 2026): 48.90 EUR
• Sector / Industry: Financials / Private Equity and Asset Management
• Index membership: SBF 120